Key TakeawaysBausch + Lomb is discussing a possible sale that would separate it from its parent company, Bausch Health Cos.Bausch Health is saddled with debt of $21 billion, nearly$10 billion of which is set to mature in 2027.In July, Bausch Health pushed back against a research firm's report that said it was mulling bankruptcy options. Bausch + Lomb (BLCO) shares popped Monday following a report that the eyecare company is considering a sale. The contact lens producer is working with Goldman Sachs (GS) on ...